Reyes-Javier, P D <br/><br/>
Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.  [electronic resource] 

 -  Acta leprologica   
 - 133-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0001-5938 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Clinical Trials as Topic<br/>Clofazimine--adverse effects<br/>Dapsone--therapeutic use<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Leprosy--drug therapy<br/>Male<br/>Middle Aged<br/>Mycobacterium leprae--isolation & purification<br/>Rifampin--therapeutic use<br/>Skin--microbiology<br/>Skin Pigmentation--drug effects